Literature DB >> 12516630

Progesterone induced blocking factor (PIBF) mediates progesterone induced suppression of decidual lymphocyte cytotoxicity.

Gordana Laskarin1, Vlatka S Tokmadzić, Natasa Strbo, Tatjana Bogović, Julia Szekeres-Bartho, Ljiljana Randić, Eckhard R Podack, Daniel Rukavina.   

Abstract

PROBLEM: Progesterone induced blocking factor (PIBF) is a mediator of progesterone that blocks peripheral blood lytic natural killer (NK) activity. Progesterone or PIBF stimulated decidual macrophages block up-regulation of perforin expression in decidual lymphocytes (DL). Therefore, we investigated whether progesterone regulates cytotoxicity of DL. METHOD OD STUDY: Decidual mononuclear cells were cultured with progesterone. PIBF, progesterone and anti-PIBF antibody or in the medium only. Cytolytic activity of non-adherent DL was measured by PKH-26 (red) 2 hr cytolytic assay and flow cytometry. Perforin positive DL were detected by immunofluorescency and PIBF-positive cells by immunohistology.
RESULTS: Progesterone and PIBF, in a dose-dependent manner decreased cytotoxicity of DL against K-562 targets, and perforin egzocytosys was blocked. Anti-PIBF antibodies reversed the progesterone mediated reduction in cytolytic activity of DL. PIBF positive cells were found in first trimester pregnancy decidua.
CONCLUSION: The results indicate possible role for PIBF, as a mediator of progesterone in regulation of DL cytolytic activity at the maternal-foetal (M-F) interface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12516630     DOI: 10.1034/j.1600-0897.2002.01133.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  15 in total

Review 1.  Evolution of non-cytotoxic uterine natural killer cells.

Authors:  Satyan Kalkunte; Clinton O Chichester; Francesca Gotsch; Charles L Sentman; Roberto Romero; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2008-05       Impact factor: 3.886

Review 2.  Immunometabolism, pregnancy, and nutrition.

Authors:  Kristin Thiele; Lianghui Diao; Petra Clara Arck
Journal:  Semin Immunopathol       Date:  2017-10-25       Impact factor: 9.623

3.  A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

Authors:  Athena P Kourtis; Lisa Haddad; Jennifer Tang; Lameck Chinula; Stacey Hurst; Jeffrey Wiener; Sascha Ellington; Julie A E Nelson; Amanda Corbett; Kristina De Paris; Caroline C King; Mina Hosseinipour; Irving F Hoffman; Denise J Jamieson
Journal:  Contemp Clin Trials       Date:  2016-11-09       Impact factor: 2.226

Review 4.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

5.  Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative.

Authors:  Elizabeth M Stringer; Mark Giganti; Rosalind J Carter; Wafaa El-Sadr; Elaine J Abrams; Jeffrey Sa Stringer
Journal:  AIDS       Date:  2009-11       Impact factor: 4.177

Review 6.  Hormonal contraception and HIV disease progression.

Authors:  Elizabeth Stringer; Erik Antonsen
Journal:  Clin Infect Dis       Date:  2008-10-01       Impact factor: 9.079

Review 7.  Endocrine factors modulating immune responses in pregnancy.

Authors:  Anne Schumacher; Serban-Dan Costa; Ana Claudia Zenclussen
Journal:  Front Immunol       Date:  2014-05-08       Impact factor: 7.561

8.  Progesterone Modulation of Pregnancy-Related Immune Responses.

Authors:  Nishel M Shah; Nesrina Imami; Mark R Johnson
Journal:  Front Immunol       Date:  2018-06-20       Impact factor: 7.561

9.  Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation.

Authors:  Nishel Mohan Shah; Anna A Herasimtschuk; Adriano Boasso; Adel Benlahrech; Dietmar Fuchs; Nesrina Imami; Mark R Johnson
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

Review 10.  Sepsis: Precision-Based Medicine for Pregnancy and the Puerperium.

Authors:  Orene Greer; Nishel Mohan Shah; Shiranee Sriskandan; Mark R Johnson
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.